Cyclin D1 and pancreatic carcinoma: a proliferative agonist and chemotherapeutic antagonist

Clin Cancer Res. 2005 Aug 15;11(16):5665-7. doi: 10.1158/1078-0432.CCR-05-1016.
No abstract available

Publication types

  • Comment

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Apoptosis / drug effects
  • Apoptosis / genetics
  • Cell Line, Tumor
  • Cell Proliferation*
  • Cell Survival / drug effects
  • Cell Survival / genetics
  • Cisplatin / pharmacology*
  • Cyclin D1 / genetics*
  • Cyclin D1 / physiology
  • Drug Resistance, Neoplasm / genetics
  • Gene Expression Regulation, Neoplastic
  • Mice
  • Mice, Transgenic
  • Pancreatic Neoplasms / genetics
  • Pancreatic Neoplasms / pathology

Substances

  • Antineoplastic Agents
  • Cyclin D1
  • Cisplatin